Can-Fite BioPharma Ltd. Registration statement for securities of certain foreign private issuers

Registration statement for securities of certain foreign private issuers

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Long-Term Investment

Long-Term Investment

12 Months Ended

Dec. 31, 2017

Long Term Investment [Abstract]

Long-Term Investment

NOTE 6:-

LONG-TERM INVESTMENT

The Company holds 8,563,254 shares of Wize Pharma Inc. (formally known as OphthaliX) as of December 31, 2017 which as of such date represents 8.2% percent of Wize Pharma Inc’s outstanding shares. The shares are classified as financial asset as designated at fair value through profit or loss.